Table 5

Total incidences of postoperative adverse events, adverse events occurring before a VTE

Adverse event	Total		Before VTE
	n=361 384		n=221 (58.47% of 378 VTE)
	n	%	n	% of VTE
Any adverse event	48 935*	13.54	221	58.47
Surgical adverse event	29 284	8.10	139	36.77
Superficial SSI	3536	0.98	6	1.59
Deep SSI	766	0.21	4	1.06
Organ/Space SSI	2766	0.77	19	5.03
Superficial wound dehiscence	3514	0.97	8	2.12
Deep wound dehiscence	1250	0.35	–	0.00
Bleeding requiring transfusion	19 454	5.38	117	30.95
Nerve injury	154	0.04	–	0.00
Flap failure	70	0.02	2	0.53
Medical adverse event	8,277*	2.29	93	24.60
Reintubation	1789	0.50	40	10.58
Pneumonia	1309	0.36	20	5.29
Sepsis	1680	0.46	25	6.61
Septic shock	299	0.08	12	3.17
CLABSI	271	0.07	9	2.38
Clostridium difficile colitis	281	0.08	–	0.00
UTI	1812	0.50	10	2.65
Renal failure	102	0.03	2	0.53
Renal insufficiency	143	0.04	1	0.26
Stroke	201	0.06	–	0.00
Seizure	584	0.16	11	2.91
Cardiac arrest	460	0.13	2	0.53
Coma	21	0.01	–	0.00
Death	1195	0.33	N/A
Reoperation	9812	2.72	57	15.08
Readmission	17 835	4.94	48	12.70

*Any adverse event and medical adverse events include all cases of VTE.
CLABSI, central line-associated bloodstream infection; N/A, not applicable; SSI, surgical site infection; UTI, urinary tract infection; VTE, venous thromboembolism.